Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction

被引:352
作者
Magid, DJ
Wang, YF
Herrin, J
McNamara, RL
Bradley, EH
Curtis, JP
Pollack, CV
French, WJ
Blaney, ME
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Cardiovasc Sect, Dept Internal Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Hlth Policy & Adm, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA
[4] Yale New Haven, Ctr Outcomes Res & Evaluat, New Haven, CT USA
[5] Penn Hosp, Philadelphia, PA 19107 USA
[6] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] Univ Colorado, Hlth Sci Ctr, Dept Emergency Med, Denver, CO USA
[9] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med, Denver, CO USA
[10] Univ Colorado, Hlth Sci Ctr, Dept Biometr, Denver, CO USA
[11] Kaiser Permanente, Clin Res Unit, Denver, CO USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 294卷 / 07期
关键词
D O I
10.1001/jama.294.7.803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Understanding how door-to-drug and door-to-balloon times vary by time of day and day of week can inform the design of interventions to improve the timeliness of reperfusion therapy. Objective To determine the pattern of door-to-drug and door-to-balloon times by time of day and day of week and whether this pattern may affect mortality. Design, Setting, and Participants Cohort study of 68439 patients with ST-segment elevation myocardial infarction (STEMI) treated with fibrinolytic therapy and 33 647 treated with percutaneous coronary intervention (PCI) from 1999 through 2002. We classified patient hospital arrival period into regular hours (weekdays, 7 AM-5 Pm) and off-hours (weekdays 5 PM-7 Am and weekends). Main Outcome Measures Geometric mean door-to-drug time for fibrinolytic therapy and door-to-balloon time for PCI and all-cause in-hospital mortality. All outcomes were adjusted for patient and hospital characteristics. Results Most fibrinolytic therapy (67.9%) and PCI patients (54.2%) were treated during off-hours. Door-to-drug times were slightly longer during off-hours (34.3. minutes) than regular hours (33.2 minutes; difference, 1.0 minute; 95% confidence interval [CI], 0.7-1.4; P<.001). In contrast, door-to-balloon times were substantially longer during off-hours (116.1 minutes) than regular hours (94.8 minutes; difference, 21.3 minutes; 95% Cl, 20.5-22.2; P<.001). A lower percentage of patients met guideline recommended times for door-to-balloon during off-hours (25.7%) than regular hours (471%; P<.001). Door-to-balloon times exceeding 120 minutes occurred much more commonly during off-hours (41.5%) than regular hours (27.7%; P<.001). Longer off-hours cloor-to-balloon times were primarily due to a longer interval between obtaining the electrocardiogram and patient arrival at the catheterization laboratory (off-hours, 69.8 minutes vs regular hours, 49.1 minutes; P<.001). This pattern was consistent across all hospital subgroups examined. Furthermore, patients presenting during off-hours had significantly higher adjusted in-hospital mortality than patients presenting during regular hours (odds ratio, 1.07; 95% Cl, 1.01-1.14; P=.02). Conclusions Presentation during off-hours was common and was associated with substantially longer times to treatment for PCI but not for fibrinolytic therapy. To achieve the best outcomes, hospitals providing PCI during off-hours should commit to doing so in a timely manner.
引用
收藏
页码:803 / 812
页数:10
相关论文
共 26 条
  • [1] *AM HOSP ASS, 1998, ANN SURV HOSP DAT DO
  • [2] Predictors of door-to-balloon delay in primary angioplasty
    Angeja, BG
    Gibson, CM
    Chin, R
    Frederick, PD
    Every, NR
    Ross, AM
    Stone, GW
    Barron, HV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (10) : 1156 - 1161
  • [3] [Anonymous], 1988, LANCET, V2, P349
  • [4] [Anonymous], 1986, LANCET, V1, P397
  • [5] Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002
  • [6] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [7] Factors associated with delay in reperfusion therapy in elderly Patients with acute myocardial infarction: Analysis of the Cooperative Cardiovascular Project
    Berger, AK
    Radford, MJ
    Krumholz, HM
    [J]. AMERICAN HEART JOURNAL, 2000, 139 (06) : 985 - 992
  • [8] Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial
    Berger, PB
    Ellis, SG
    Holmes, DR
    Granger, CB
    Criger, DA
    Betriu, A
    Topol, EJ
    Califf, RM
    [J]. CIRCULATION, 1999, 100 (01) : 14 - 20
  • [9] Bland JM, 1996, BRIT MED J, V312, P1079
  • [10] Hospital-level performance improvement - Beta-blocker use after acute myocardial infarction
    Bradley, EH
    Herrin, J
    Mattera, JA
    Holmboe, ES
    Wang, YF
    Frederick, P
    Roumanis, SA
    Radford, MJ
    Krumhoz, HM
    [J]. MEDICAL CARE, 2004, 42 (06) : 591 - 599